mycaminosyltylonolide and Bacterial-Infections

mycaminosyltylonolide has been researched along with Bacterial-Infections* in 2 studies

Other Studies

2 other study(ies) available for mycaminosyltylonolide and Bacterial-Infections

ArticleYear
Synthesis, antimicrobial evaluation and structure-activity relationships within 23-modified derivatives of 5-O-mycaminosyltylonolide.
    The Journal of antibiotics, 1987, Volume: 40, Issue:6

    A large series of C-23-modified derivatives of 5-O-mycaminosyltylonolide were synthesized, in which the C-23 hydroxyl group was replaced by halo, aryl ether or thioether, azido, amino or dialkylamino substituents via SN2 displacement reactions. The majority of derivatives possessed excellent in vitro activity against a variety of aerobic and anaerobic bacteria. While some of the compounds treated experimental infections in rodents by parenteral administration, none showed any significant efficacy or bioavailability after oral dosing. Novel rearrangement products were obtained from some of the reactions; these were identified as 13,23-cyclopropyl-12,22-exomethylene and 13,23-cyclopropyl-12-alkoxy derivatives.

    Topics: Animals; Bacterial Infections; Chemical Phenomena; Chemistry; Dogs; Gram-Negative Bacteria; Gram-Positive Bacteria; Leucomycins; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

1987
Synthesis and antimicrobial evaluation of acyl derivatives of 16-membered macrolide antibiotics related to tylosin.
    The Journal of antibiotics, 1986, Volume: 39, Issue:8

    A large number and wide variety of acyl derivatives of the tylosin-related macrolides 23-demycinosyltylosin (DMT), 23-demycinosyloxytylosin (DMOT) and 5-O-mycaminosyltylonolide (OMT) were synthesized and evaluated. This encompassed conversion of the hydroxyl groups at 2',4' and 23 of the appropriate macrolides to the corresponding esters, in which a variety of different substitution patterns were examined. A wide range of acyl substituents was investigated, particularly for 23-O-acyl derivatives of OMT, since these were substantially more active in vitro than OMT itself. However, the acyl derivatives which were prepared demonstrated no substantial improvement in oral efficacy or bioavailability over the parent macrolides.

    Topics: Acylation; Animals; Bacteria; Bacterial Infections; Leucomycins; Mice; Structure-Activity Relationship

1986